Why is Kimia Bioscien. falling/rising?

As of 23-Sep, Kimia Biosciences Ltd is experiencing a decline in its stock price, currently at Rs 35.94, which reflects a decrease of Rs 1.2 or 3.23%. The stock has been underperforming, having fallen consecutively for the last two days, resulting in a total decline of 4.11% during this period. It opened with a significant loss of 4.66% today and is trading close to its 52-week low, just 4.7% above Rs 34.25. Additionally, the company's net sales and profit after tax have seen substantial declines, with net sales falling by 20.7% and PAT dropping by 75% compared to previous averages. The company is characterized by high debt levels, with a debt-to-equity ratio averaging 12.14 times, and has shown poor long-term growth, which contributes to its negative performance.
In the broader market context, Kimia Biosciences has underperformed against the benchmark, the Sensex, which has shown a slight decline of 0.34% over the past week, while Kimia's stock has gained 3.87% in the same timeframe. However, over the longer term, Kimia has consistently lagged behind the benchmark, with a year-to-date return of -21.27% compared to the Sensex's gain of 5.07%. This consistent underperformance, coupled with falling investor participation and liquidity issues, suggests a lack of confidence among investors, further exacerbating the stock's decline.